The plant genus Aglaia (Meliaceae) from the tropical rain forests of Indonesia and Malaysia is the source of a unique group of natural products featuring unique and densely functionalized ring systems (Figure 1 , Curr. Org. Chem. 2001, 5, 923-938). One class of compounds from this genus possess a cyclopenta [b]tetrahydrobenzofuran ring system and includes compounds such as rocaglamide (1), aglaroxin C (2), cyclorocaglamide (3), and the recently isolated dioxanyloxy-modified derivative silvestrol (4) (J. Org. Chem. 2004, 69, 3350-3358). The structurally related aglains containing a cyclopenta[bc]benzopyran ring system (e.g. thapsakon (5) and aglaforbesin (6)) have also been isolated from Aglaia. The original report on the isolation of rocaglamide revealed that 1 also exhibited potent anticancer activity (IC 50 = 1.0 ng/mL) against KB and P388 human cancer cell lines. Subsequent studies have indicated that rocaglamides exhibit potent antiproliferative and antileukemic activities (Chemico-biological interactions 1998, 115, 215-228) and also inhibit TNF-α or PMAinduced NF-κB activity in the nanomolar range in human T cell lines. ( J. Biol. Chem. 2002, 277, 44791-44800) The most recently isolated rocaglate, silvestrol 4, displays cytotoxic activity against human cancer cell lines comparable to the anticancer drug paclitaxel (Taxol).
Recently, we have reported a unified biomimetic approach to the aglain-forbaglinrocaglamide classes of natural products ("A Biomimetic Approach to the Rocaglamides Employing Photogeneration of Oxidopyryliums Derived from 3-Hydroxyflavones." Gerard, B.; Jones, G., II.; Porco, J. A., Jr. J. Am. Chem. Soc. 2004, 126, 13620-13621) . The overall approach (Figure 2 ) involves photogeneration of oxidopyryliums via Excited State Intramolecular Proton Transfer (ESIPT) of 3-hydroxyflavones followed by [3+2] dipolar cycloaddition to afford the aglain core. A α-ketol (acyloin) rearrangement was employed to transform the aglain core to the rocaglamide framework. This approach was successfully used for the synthesis of the natural product (±)-methyl rocaglate. Synthesis of additional rocaglamide family members is currently underway. 
